HKG Equity Snapshot
9606 Weekly Equity Report
Duality Biotherapeutics, Inc.
What the company does
Duality Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others. The company provides DB-1303/BNT323, a HER2 ADC candidate targeting cancers, including endometrial cancer1 and breast cancer2; DB-1311/BNT324, a B7-H3 ADC candidate targeting cancers, such as small-cell lung cancer3, castration-resistant prostate cancer4, esophageal squamous cell carcinoma5, and head and neck squamous cell carcinoma; and other clinical-stage ADCs. It has strategic partnerships with BioNTech SE to develop therapies to complement or replace chemotherapy; and BeOne to develop and commercialize DB-1312, an in-house discovered B7-H4- targeted ADC. …
What the weekly tape is saying
9606 closed the latest completed week at 186.1 HKD. The 4-week return is -18.8% and the 12-week return is -33.6%. Trend Signal is inactive, Market Dynamics is -1.63. Setup signature: Risk-first tape with a 14/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 297.7 HKD
- Vs Trend Line
- -37.5%
- Fair Value
- 295.5 HKD
- Vs Fair Value
- -37.0%
- 52W High
- 563.5 HKD
- 52W Low
- 162.3 HKD
- Drawdown
- -67.0%
- Range Position
- 5.9%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 9
- 52W Active Breadth
- 17.3%
- Sector Scope
- HK Healthcare
- Sector Rank
- 104 of 257
- Sector Percentile
- 59.8%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
HK Healthcare
- Tracked Peers
- 100
- 4W Rank
- 76 of 100
- Avg 1W
- -1.3%
- Avg 4W
- -12.8%
- Trend Breadth
- 6.0%
- Positive MD
- 10.0%
HK Biotechnology
- Tracked Peers
- 76
- 4W Rank
- 41 of 76
- Avg 1W
- -1.6%
- Avg 4W
- -17.5%
- Trend Breadth
- 3.9%
- Positive RS
- 5.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.63
- 4W MD Change
- -6.7%
- Relative Strength
- -37.42
- 4W RS Change
- -37.0%
- Expectation
- Undecided
- Probability
- 47.85%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 5.7M
- 13W Average
- 4.5M
- 52W Average
- 4.1M
- Vs 13W
- 1.3x
- Vs 52W
- 1.4x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 7.4%
- 52W Volatility
- 10.0%
- Upside Weeks
- 22
- Downside Weeks
- 30
- Downside Breadth
- 57.7%
- Avg Gain / Loss
- 9.2% / -7.2%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- HKG
- Country
- HK
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- HKD
- Market Cap
- 18.5B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 186.1 HKD | -0.3% | 297.7 HKD | 295.5 HKD | -1.63 | -37.42 | 5.7M | Off |
| 5 Jun 2026 | 186.6 HKD | -17.3% | 302.7 HKD | 297.4 HKD | -1.63 | -38.25 | 6.5M | Off |
| 29 May 2026 | 225.6 HKD | 1.3% | 306.0 HKD | 299.2 HKD | -1.67 | -26.18 | 4.2M | Off |
| 22 May 2026 | 222.8 HKD | -2.8% | 309.0 HKD | 300.5 HKD | -1.62 | -28.31 | 5.0M | Off |
| 15 May 2026 | 229.2 HKD | -10.5% | 311.2 HKD | 301.9 HKD | -1.53 | -27.31 | 6.0M | Off |
| 8 May 2026 | 256.0 HKD | -7.2% | 314.7 HKD | 303.2 HKD | -1.34 | -20.07 | 3.6M | Off |
| 1 May 2026 | 276.0 HKD | -5.7% | 316.0 HKD | 304.0 HKD | -1.04 | -11.62 | 1.9M | Off |
| 24 Apr 2026 | 292.6 HKD | -5.8% | 318.2 HKD | 304.6 HKD | -0.78 | -6.86 | 3.2M | Off |
| 17 Apr 2026 | 310.6 HKD | 2.5% | 319.7 HKD | 304.8 HKD | -0.79 | -1.54 | 4.9M | Off |
| 10 Apr 2026 | 303.0 HKD | -6.4% | 322.5 HKD | 304.7 HKD | -0.93 | -2.57 | 6.3M | Off |
| 3 Apr 2026 | 323.6 HKD | 13.9% | 327.5 HKD | 304.7 HKD | -1.10 | - | 3.7M | Off |
| 27 Mar 2026 | 284.2 HKD | 1.4% | 328.8 HKD | 304.3 HKD | -1.05 | - | 4.6M | Off |
| 20 Mar 2026 | 280.2 HKD | 3.6% | 329.8 HKD | 304.7 HKD | -0.88 | - | 3.4M | Off |
| 13 Mar 2026 | 270.4 HKD | -14.3% | 331.9 HKD | 305.2 HKD | -0.60 | - | 5.4M | Off |